Cullinan Oncology Inc
NASDAQ:CGEM
Cullinan Oncology Inc
NASDAQ:CGEM
Price:
24.914 USD
-6.76%
Market Closed
Updated:
May 16, 2024
Cullinan Oncology Inc
Total Other Income
|
Cullinan Oncology Inc
Total Other Income Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cullinan Oncology Inc
NASDAQ:CGEM
|
Total Other Income
$239k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-204%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$252m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Cullinan Oncology Inc's Total Other Income?
Total Other Income
239k
USD
239k
USD
Based on the financial report for Dec 31, 2023, Cullinan Oncology Inc's Total Other Income amounts to 239k USD.
What is Cullinan Oncology Inc's Total Other Income growth rate?
Total Other Income CAGR 1Y
298%
298%
Over the last year, the Total Other Income growth was 298%.
You don't have any saved screeners yet
